Long-Term Management of Hepatitis C-Seropositive Subjects with AntiOxidant Biofactor (AOB®), a Fermented Food Supplement
スポンサーリンク
概要
- 論文の詳細を見る
The efficacy of AntiOxidant Biofactor (AOB(R)) for the management of apparently healthy subjects with chronic hepatitis C infection was investigated. A total of 60 subjects (35 males, 25 females) participated in the trial. AOB was given orally in 2 packs (3g per pack) 3 times per day. 17 subjects had taken AOB for 3 years, 31 subjects up to 2 years, and 41 subjects up to one year. The initial mean (SD) serum alamine aminotransferase (ALT) level was 46.3+/-35.4IU/L, and significant (p0.05, paired t-test) reductions in the mean serum ALT levels were observed at 6 months (38.6+/-21.5IU/L), 18 months (31.9+/-18.1IU/L), 2 years (31.2+/-14.6IU/L), and 3 years (28.0+/-15.9IU/L). Those presenting with high serum ALT levels (30 subjects) demonstrated significant levels (p0.05, paired t-test) of reduction in the mean serum ALT levels at 6, 12, 18, 24, and 36 months of treatment. No side effects were observed and the AOB treatment was well tolerated by all subjects.
論文 | ランダム
- 14.建築現場施工の合理化に関する研究 第三報 : 塗壁工法の動作研究(第2部(材料・施工関係))
- 23pGC-2 Ce_xLa_Ru_2Si_2混晶系のCe希薄領域でのフェルミ面の変化III(23pGC メタ磁性・重い電子系,領域8(強相関系:高温超伝導,強相関f電子系など))
- 名古屋高速道路の設計と施工
- 特発性冠動脈解離により急性心筋梗塞を発症した一例
- ストーマ・褥瘡ケアにおける看護の専門性--東京医科歯科大学医学部附属病院外来研修を通して